Gavin T. Malenfant - 07 Jul 2022 Form 3 Insider Report for ProMIS Neurosciences Inc. (PMN)

Role
Chief Operating Officer
Signature
/s/ Jason L. Langford, Attorney-in-Fact for Gavin T. Malenfant
Issuer symbol
PMN
Transactions as of
07 Jul 2022
Net transactions value
$0
Form type
3
Filing time
07 Jul 2022, 19:26:51 UTC
Next filing
25 Aug 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding PMN Option (right to buy) 07 Jul 2022 Common Shares 58,333 $11.40 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Conversion or exercise price is in Canadian dollars.
F2 The option agreement provides that the option vested 1/4 immediately with the balance vesting ratably over 36 months. The option was granted on September 22, 2021.

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney